These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
203 related items for PubMed ID: 9861021
1. Loss of function of the tuberous sclerosis 2 tumor suppressor gene results in embryonic lethality characterized by disrupted neuroepithelial growth and development. Rennebeck G, Kleymenova EV, Anderson R, Yeung RS, Artzt K, Walker CL. Proc Natl Acad Sci U S A; 1998 Dec 22; 95(26):15629-34. PubMed ID: 9861021 [Abstract] [Full Text] [Related]
2. Renal carcinogenesis, hepatic hemangiomatosis, and embryonic lethality caused by a germ-line Tsc2 mutation in mice. Kobayashi T, Minowa O, Kuno J, Mitani H, Hino O, Noda T. Cancer Res; 1999 Mar 15; 59(6):1206-11. PubMed ID: 10096549 [Abstract] [Full Text] [Related]
3. Tuberous sclerosis as an underlying basis for infantile spasm. Yeung RS. Int Rev Neurobiol; 2002 Mar 15; 49():315-32. PubMed ID: 12040899 [Abstract] [Full Text] [Related]
4. Sustained cardiomyocyte DNA synthesis in whole embryo cultures lacking the TSC2 gene product. Pajak L, Jin F, Xiao GH, Soonpaa MH, Field LJ, Yeung RS. Am J Physiol; 1997 Sep 15; 273(3 Pt 2):H1619-27. PubMed ID: 9321857 [Abstract] [Full Text] [Related]
5. Suppression of tumorigenicity by the wild-type tuberous sclerosis 2 (Tsc2) gene and its C-terminal region. Jin F, Wienecke R, Xiao GH, Maize JC, DeClue JE, Yeung RS. Proc Natl Acad Sci U S A; 1996 Aug 20; 93(17):9154-9. PubMed ID: 8799170 [Abstract] [Full Text] [Related]
6. Localization of tuberous sclerosis 2 mRNA and its protein product tuberin in normal human brain and in cerebral lesions of patients with tuberous sclerosis. Kerfoot C, Wienecke R, Menchine M, Emelin J, Maize JC, Welsh CT, Norman MG, DeClue JE, Vinters HV. Brain Pathol; 1996 Oct 20; 6(4):367-75. PubMed ID: 8944308 [Abstract] [Full Text] [Related]
7. Genetic variants of the tuberous sclerosis 2 tumour suppressor gene in mouse t haplotypes. Kleymenova EV, Declue JE, Walker CL. Genet Res; 1999 Oct 20; 74(2):139-44. PubMed ID: 10584558 [Abstract] [Full Text] [Related]
8. The GAP-related domain of tuberin, the product of the TSC2 gene, is a target for missense mutations in tuberous sclerosis. Maheshwar MM, Cheadle JP, Jones AC, Myring J, Fryer AE, Harris PC, Sampson JR. Hum Mol Genet; 1997 Oct 20; 6(11):1991-6. PubMed ID: 9302281 [Abstract] [Full Text] [Related]
9. Role of the tuberous sclerosis gene-2 product in cell cycle control. Loss of the tuberous sclerosis gene-2 induces quiescent cells to enter S phase. Soucek T, Pusch O, Wienecke R, DeClue JE, Hengstschläger M. J Biol Chem; 1997 Nov 14; 272(46):29301-8. PubMed ID: 9361010 [Abstract] [Full Text] [Related]
10. Mourning Dr. Alfred G. Knudson: the two-hit hypothesis, tumor suppressor genes, and the tuberous sclerosis complex. Hino O, Kobayashi T. Cancer Sci; 2017 Jan 14; 108(1):5-11. PubMed ID: 27862655 [Abstract] [Full Text] [Related]
11. Inactivation of the cyclin-dependent kinase inhibitor p27 upon loss of the tuberous sclerosis complex gene-2. Soucek T, Yeung RS, Hengstschläger M. Proc Natl Acad Sci U S A; 1998 Dec 22; 95(26):15653-8. PubMed ID: 9861025 [Abstract] [Full Text] [Related]
12. Transgenic expression of the N525S-tuberin variant in Tsc2 mutant (Eker) rats causes dominant embryonic lethality. Shiono M, Kobayashi T, Takahashi R, Ueda M, Ishioka C, Hino O. Sci Rep; 2014 Aug 04; 4():5927. PubMed ID: 25088526 [Abstract] [Full Text] [Related]
13. Morphology of cerebral lesions in the Eker rat model of tuberous sclerosis. Wenzel HJ, Patel LS, Robbins CA, Emmi A, Yeung RS, Schwartzkroin PA. Acta Neuropathol; 2004 Aug 04; 108(2):97-108. PubMed ID: 15185103 [Abstract] [Full Text] [Related]
14. Absence of allelic loss in cytomegalic neurons of cortical tuber in the Eker rat model of tuberous sclerosis. Mizuguchi M, Mori M, Nozaki Y, Momoi MY, Itoh M, Takashima S, Hino O. Acta Neuropathol; 2004 Jan 04; 107(1):47-52. PubMed ID: 14566415 [Abstract] [Full Text] [Related]
15. Polycystic kidney disease as a result of loss of the tuberous sclerosis 2 tumor suppressor gene during development. Cai S, Everitt JI, Kugo H, Cook J, Kleymenova E, Walker CL. Am J Pathol; 2003 Feb 04; 162(2):457-68. PubMed ID: 12547704 [Abstract] [Full Text] [Related]
16. Germ-line mutational analysis of the TSC2 gene in 90 tuberous-sclerosis patients. Au KS, Rodriguez JA, Finch JL, Volcik KA, Roach ES, Delgado MR, Rodriguez E, Northrup H. Am J Hum Genet; 1998 Feb 04; 62(2):286-94. PubMed ID: 9463313 [Abstract] [Full Text] [Related]
17. Presence of potent transcriptional activation domains in the predisposing tuberous sclerosis (Tsc2) gene product of the Eker rat model. Tsuchiya H, Orimoto K, Kobayashi K, Hino O. Cancer Res; 1996 Feb 01; 56(3):429-33. PubMed ID: 8564946 [Abstract] [Full Text] [Related]
18. Reduction of expression of tuberin, the tuberous-sclerosis-complex-gene-2 product in tuberous sclerosis complex associated connective tissue nevi and sporadic squamous and basal cell carcinomas. Wienecke R, Klemm E, Karparti S, Swanson NA, Green AJ, DeClue JE. J Cutan Pathol; 2002 May 01; 29(5):287-90. PubMed ID: 12100629 [Abstract] [Full Text] [Related]
19. Loss of tuberin, the tuberous-sclerosis-complex-2 gene product is associated with angiogenesis. Nguyen-Vu PA, Fackler I, Rust A, DeClue JE, Sander CA, Volkenandt M, Flaig M, Yeung RS, Wienecke R. J Cutan Pathol; 2001 Oct 01; 28(9):470-5. PubMed ID: 11553313 [Abstract] [Full Text] [Related]
20. Identification of the coding sequences responsible for Tsc2-mediated tumor suppression using a transgenic rat system. Momose S, Kobayashi T, Mitani H, Hirabayashi M, Ito K, Ueda M, Nabeshima Y, Hino O. Hum Mol Genet; 2002 Nov 15; 11(24):2997-3006. PubMed ID: 12417521 [Abstract] [Full Text] [Related] Page: [Next] [New Search]